ARCA biopharma Inc (ABIO)
3.24
-0.01
(-0.31%)
USD |
NASDAQ |
May 02, 16:00
3.25
+0.01
(+0.31%)
After-Hours: 20:00
ARCA biopharma Cash from Operations (Quarterly): -1.528M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.528M |
| December 31, 2023 | -1.056M |
| September 30, 2023 | -1.669M |
| June 30, 2023 | -0.694M |
| March 31, 2023 | -1.595M |
| December 31, 2022 | -1.494M |
| September 30, 2022 | -2.498M |
| June 30, 2022 | -2.622M |
| March 31, 2022 | -4.298M |
| December 31, 2021 | -4.947M |
| September 30, 2021 | -4.87M |
| June 30, 2021 | -3.72M |
| March 31, 2021 | -5.225M |
| December 31, 2020 | -2.995M |
| September 30, 2020 | -2.002M |
| June 30, 2020 | -1.042M |
| March 31, 2020 | -1.686M |
| December 31, 2019 | -1.158M |
| September 30, 2019 | -0.887M |
| June 30, 2019 | -1.19M |
| March 31, 2019 | -1.566M |
| December 31, 2018 | -1.343M |
| September 30, 2018 | -1.576M |
| June 30, 2018 | -2.254M |
| March 31, 2018 | -3.071M |
| Date | Value |
|---|---|
| December 31, 2017 | -4.196M |
| September 30, 2017 | -3.974M |
| June 30, 2017 | -4.958M |
| March 31, 2017 | -4.344M |
| December 31, 2016 | -3.842M |
| September 30, 2016 | -3.736M |
| June 30, 2016 | -3.526M |
| March 31, 2016 | -3.883M |
| December 31, 2015 | -2.62M |
| September 30, 2015 | -2.402M |
| June 30, 2015 | -2.399M |
| March 31, 2015 | -3.113M |
| December 31, 2014 | -1.879M |
| September 30, 2014 | -2.077M |
| June 30, 2014 | -1.763M |
| March 31, 2014 | -3.687M |
| December 31, 2013 | -1.872M |
| September 30, 2013 | -1.676M |
| June 30, 2013 | -0.976M |
| March 31, 2013 | -0.764M |
| December 31, 2012 | -0.67M |
| September 30, 2012 | -0.775M |
| June 30, 2012 | -0.977M |
| March 31, 2012 | -1.656M |
| December 31, 2011 | -1.236M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.225M
Minimum
Mar 2021
-0.694M
Maximum
Jun 2023
-2.359M
Average
-1.678M
Median
Cash from Operations (Quarterly) Benchmarks
| Shockwave Medical Inc | 71.70M |
| Asensus Surgical Inc | -13.37M |
| Glaukos Corp | -10.66M |
| Helius Medical Technologies Inc | -2.034M |
| Perspective Therapeutics Inc | -9.008M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -4.947M |
| Free Cash Flow Per Share (Quarterly) | -0.1054 |
| Free Cash Flow Yield | -10.57% |